Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT06976970

Diet Quality And Metabolic Syndrome In Adult Individuals: Evaluation Of Turkey Nutrition And Health Survey 2017

This study investigates how the quality of a person's diet may be related to metabolic syndrome, which includes health issues such as high blood pressure, high blood sugar, and abdominal obesity. The research uses existing data from the 2017 Turkey Nutrition and Health Survey, focusing on adults aged 19 and over. The study does not involve any medical treatments or new data collection. It aims to support public health efforts by identifying links between eating patterns and metabolic health in the Turkish population.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Notify Me

Key information

Age range

19 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Ondokuz Mayıs University

Samsun, Turkey (Türkiye)

About this study

This study is a secondary analysis of the 2017 Turkey Nutrition and Health Survey (TNHS), which was conducted by the Ministry of Health to assess the health and nutritional status of the Turkish population. The objective of this cross-sectional observational study is to evaluate the relationship between diet quality and the presence of metabolic syndrome (MetS) among Turkish adults aged 19 years and older.

Diet quality will be assessed using several validated dietary indices, including the Healthy Eating Index-2015 (HEI-2015), the Dietary Inflammatory Index (DII), the modified Mediterranean Diet Score (MDS), and the DASH (Dietary Approaches to Stop Hypertension) score. These indices provide a comprehensive evaluation of overall dietary patterns and their potential impact on metabolic health.

Metabolic syndrome will be defined based on the Joint Interim Statement (2009) criteria. Participants will be classified as having metabolic syndrome if at least three of the following five components are present: abdominal obesity, elevated blood pressure or receiving antihypertensive treatment, reduced HDL cholesterol levels or receiving treatment for dyslipidemia, elevated triglyceride levels or receiving lipid-lowering therapy, and elevated fasting blood glucose or receiving treatment for hyperglycemia.

Statistical analysis will include descriptive statistics, t-tests or Mann-Whitney U tests for comparisons between MetS and non-MetS groups, and multivariate logistic regression analyses to determine the associations between dietary indices and the likelihood of having MetS, adjusting for relevant sociodemographic and lifestyle covariates.

Statistical analyses were conducted using SPSS version 22.0. Descriptive statistics included frequencies and percentages for categorical variables and means with standard deviations or medians with ranges for continuous variables, depending on the distribution. Normality was assessed using the Shapiro-Wilk test. Group comparisons were performed using the Mann-Whitney U test or Kruskal-Wallis test for non-normally distributed variables and the Chi-square test for categorical variables. Correlations between continuous variables were evaluated using Spearman's rank correlation coefficient. Binary logistic regression analysis was used to identify factors associated with the presence of metabolic syndrome. A p-value of <0.05 was considered statistically significant.

This study is expected to contribute to the national evidence base on dietary patterns and metabolic health and to inform public health strategies aiming to reduce the burden of non-communicable diseases in Turkiye.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 19 years and older
  • Participated in the 2017 Turkey Nutrition and Health Survey (TNHS)

Exclusion criteria

  • Pregnant or lactating women, individuals with cancer, psychiatric or neurological disorders, those on specific therapeutic diets, individuals with missing key variables, and those with implausible energy intake levels (<800 or >4000 kcal/day for men, <500 or >3500 kcal/day for women).

Treatment and study plan

Primary outcomes

  1. Metabolic Syndrome (MetS)

    Time frame: Day 1

    The primary outcome is the presence or absence of metabolic syndrome, defined according to the Joint Interim Statement criteria (2009). Participants are classified as having MetS if they meet at least three of the following five components: abdominal obesity, elevated blood pressure, elevated fasting glucose, elevated triglycerides, and reduced HDL cholesterol.

  2. HEI-2015 Score

    Time frame: Day 1

    Diet quality will be assessed using the Healthy Eating Index-2015 (HEI-2015).

  3. Dietary Inflammatory Index (DII)

    Time frame: Day 1

    Diet quality will be assessed using the Dietary Inflammatory Index (DII).

  4. Mediterranean Diet Score (MDS)

    Time frame: Day 1

    Diet quality will be assessed using the Mediterranean Diet Score (MDS).

  5. DASH Score (Dietary Approaches to Stop Hypertension)

    Time frame: Day 1

    Diet quality will be assessed using the DASH (Dietary Approaches to Stop Hypertension) score.

Sponsors and collaborators

Lead sponsor

Elif Akbas

Other

Registry information

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
May 16, 2025
Registry last updated
May 16, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.